ASBM Releases Fact Sheet on Emerging Challenges to Interchangeable Biosimilars Policy
February 5, 2024
On January 31st, ASBM released a fact sheet describing a variety of proposed policy changes at the state and federal level which would weaken the interchangeable biosimilar standard, or circumvent the patient protections it provides. These include new bills and regulations at the federal level, as well as state legislation and proposals which threaten to […]